R S Chang

559 total citations
9 papers, 478 citations indexed

About

R S Chang is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, R S Chang has authored 9 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in R S Chang's work include Receptor Mechanisms and Signaling (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Renin-Angiotensin System Studies (2 papers). R S Chang is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Renin-Angiotensin System Studies (2 papers). R S Chang collaborates with scholars based in United States, Australia and China. R S Chang's co-authors include Victor J. Lotti, Peter K. S. Siegl, W. J. GREENLEE, Nathan B. Mantlo, Probir Chakravarty, A. A. PATCHETT, Bradley V. Clineschmidt, Ann L. Scott, Charles S. Sweet and Debra L. Ondeyka and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

R S Chang

9 papers receiving 459 citations

Peers

Countries citing papers authored by R S Chang

Since Specialization

Citations

This map shows the geographic impact of R S Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R S Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R S Chang more than expected).

Fields of papers citing papers by R S Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R S Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R S Chang. The network helps show where R S Chang may publish in the future.

Co-authorship network of co-authors of R S Chang

This figure shows the co-authorship network connecting the top 25 collaborators of R S Chang. A scholar is included among the top collaborators of R S Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R S Chang. R S Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Effects of insulin-like growth factor-1 on okadaic acid-induced apoptosis in SH-SY5Y cells 2005 ·Cell Biology International ·Chunxiao Xing, (unknown), R S Chang, Yongkai Yin, Zhiping Xie	14
2	Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective α1a-adrenergic receptor antagonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Bharat Lagu, (unknown), George Chiu, Dhanapalan Nagarathnam, James C. Fang, Quanrong Shen, Carlos Forray, Richard W. Ransom, R S Chang, Kamlesh P. Vyas, (unknown), Charles Gluchowski	39
3	Impact of recounting trauma stories on the emotional state of Cambodian refugees 1995 ·Psychiatric Services ·Derrick Silove, R S Chang, Vijaya Manicavasagar	12
4	In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), R S Chang, Peter K. S. Siegl, R.E. Gibson	28
5	Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates 1993 ·Journal of Medicinal Chemistry ·Wallace T. Ashton, Steven M. Hutchins, W. J. GREENLEE, George A. Doss, R S Chang, Victor J. Lotti, (unknown), (unknown), Gloria J. Zingaro	45
6	Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Ann L. Scott, R S Chang, Victor J. Lotti, Peter K. S. Siegl	45
7	In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Peter K. S. Siegl, R S Chang, Nathan B. Mantlo, Probir Chakravarty, Debra L. Ondeyka, W. J. GREENLEE, A. A. PATCHETT, Charles S. Sweet, Victor J. Lotti	88
8	In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·R S Chang, Peter K. S. Siegl, Bradley V. Clineschmidt, Nathan B. Mantlo, Probir Chakravarty, W. J. GREENLEE, A. A. PATCHETT, Victor J. Lotti	98
9	Angiotensin receptor subtypes in rat, rabbit and monkey tissues: Relative distribution and species dependency 1991 ·Life Sciences ·R S Chang, Victor J. Lotti	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact